Terazosin and Parkinson's Disease Extension Study
NCT05109364
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Symptomatic Parkinson Disease
REM Sleep Behavior Disorder
Pre-motor Parkinson's Disease
Interventions
DRUG:
Terazosin therapy
Sponsor
Cedars-Sinai Medical Center